Celldex Therapeutics, Inc. (CLDX) › Shares OutstandingCelldex Therapeutics, Inc. (CLDX) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2010: 32.06M2011: 44.21M2012: 64.36M2013: 89.25M2014: 89.59M2015: 98.69M2016: 120.52M2017: 9.23M2018: 11.96M2019: 16.97M2020: 39.60M2021: 46.73M2022: 47.20M2023: 55.88M2024: 66.37M2025: 66.55M66.55M2010Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202566.55M+0.3%202466.37M+18.8%202355.88M+18.4%202247.20M+1.0%202146.73M+18.0%202039.60M+133.3%201916.97M+41.9%201811.96M+29.5%20179.23M-92.3%2016120.52M+22.1%201598.69M+10.1%201489.59M+0.4%201389.25M+38.7%201264.36M+45.6%201144.21M+37.9%201032.06M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share